Correlation Between Genscript Biotech and Ovid Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Ovid Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Ovid Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Ovid Therapeutics, you can compare the effects of market volatilities on Genscript Biotech and Ovid Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Ovid Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Ovid Therapeutics.

Diversification Opportunities for Genscript Biotech and Ovid Therapeutics

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Genscript and Ovid is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Ovid Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ovid Therapeutics and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Ovid Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ovid Therapeutics has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Ovid Therapeutics go up and down completely randomly.

Pair Corralation between Genscript Biotech and Ovid Therapeutics

Assuming the 90 days horizon Genscript Biotech is expected to under-perform the Ovid Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Genscript Biotech is 1.4 times less risky than Ovid Therapeutics. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Ovid Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  346.00  in Ovid Therapeutics on August 29, 2024 and sell it today you would lose (237.00) from holding Ovid Therapeutics or give up 68.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Genscript Biotech  vs.  Ovid Therapeutics

 Performance 
       Timeline  
Genscript Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genscript Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Ovid Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ovid Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Ovid Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Genscript Biotech and Ovid Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genscript Biotech and Ovid Therapeutics

The main advantage of trading using opposite Genscript Biotech and Ovid Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Ovid Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ovid Therapeutics will offset losses from the drop in Ovid Therapeutics' long position.
The idea behind Genscript Biotech and Ovid Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets